Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Checkpoint inhibitor extended survival by about three months compared with chemotherapy.
April is Esophageal Cancer Awareness Month.
Many people with GI cancers are diagnosed only after the disease has spread through the body, so this test could aid in early detection.
A consortium of health providers and researchers hopes to raise public awareness of how exercise can benefit those living with cancer.
pembrolizumab’s efficacy was investigated in two clinical trials of people with recurrent, locally advanced or metastatic disease.
A low dose of platinum-based chemotherapy worked as well as higher doses for elderly and frail people with esophageal and stomach cancer.
Cancer cause and cure headlines can often be confusing or misleading.
A third of patients taking neoadjuvant Opdivo for inoperable advanced liver cancer had complete responses in an early analysis.
Changes include approval of new drug therapies, using existing drugs more effectively and revising protocols to reduce toxic side effects.
Keytruda improved survival in people with favorable tumor biomarkers.
Liver fat may be a driver of increased cancer risk associated with obesity.
When heartburn becomes a regular occurrence, the issue may merit a closer look from your healthcare professional
Blood tests for cancer DNA, protein biomarkers and circulating tumor cells may make it easier to catch cancer early.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.